Back to top

Image: Bigstock

Top Ranked Value Stocks to Buy for January 30th

Read MoreHide Full Article

Here are three stocks with buy rank and strong value characteristics for investors to consider today, January 30th:

Banco Macro S.A. (BMA - Free Report) : This company that provides various banking products and services to individuals and corporate customers has a Zacks Rank #1 (Strong Buy), and seen the Zacks Consensus Estimate for its current year earnings rising 28.8% over the last 60 days.

Macro Bank Inc. Price and Consensus

Banco Macro has a price-to-earnings ratio (P/E) of 3.11 compared with 5.20 for the industry. The company possesses a Value Score of A.

Macro Bank Inc. PE Ratio (TTM)

American Equity Investment Life Holding Company (AEL - Free Report) : This provider of life insurance products and services has a Zacks Rank #1 (Strong Buy), and seen the Zacks Consensus Estimate for its current year earnings rising 39.1% over the last 60 days.

American Equity Investment Life Holding Company Price and Consensus

American Equity Investment has a price-to-earnings ratio (P/E) of 6.54 compared with 12.90 for the industry. The company possesses a Value Score of A.

American Equity Investment Life Holding Company PE Ratio (TTM)

H&R Block, Inc. (HRB - Free Report) : This provider of assisted income tax return preparation services has a Zacks Rank #1 (Strong Buy), and seen the Zacks Consensus Estimate for its current year earnings rising 21.9% over the last 60 days.

H&R Block, Inc. Price and Consensus

H&R Block has a price-to-earnings ratio (P/E) of 9.68 compared with 29.30 for the industry. The company possesses a Value Score of A.

H&R Block, Inc. PE Ratio (TTM)

See the full list of top ranked stocks here

Learn more about the Value score and how it is calculated here.

Find more top income stocks with some of our great premium screens.

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>


In-Depth Zacks Research for the Tickers Above


Normally $25 each - click below to receive one report FREE:


H&R Block, Inc. (HRB) - free report >>

Macro Bank Inc. (BMA) - free report >>

American Equity Investment Life Holding Company (AEL) - free report >>

Published in